Influence of physical activity on active surveillance discontinuation in men with low-risk prostate cancer

被引:5
|
作者
Papadopoulos, Efthymios [1 ,2 ]
Alibhai, Shabbir M. H. [2 ,3 ,4 ]
Tomlinson, George A. [3 ,4 ,6 ]
Matthew, Andrew G. [3 ,4 ]
Nesbitt, Michael [5 ]
Finelli, Antonio [3 ,5 ]
Trachtenberg, John [3 ,5 ]
Santa Mina, Daniel [1 ,2 ,3 ]
机构
[1] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada
[2] Princess Margaret Canc Ctr, Dept Support Care, Toronto, ON, Canada
[3] Univ Toronto, Fac Med, Toronto, ON, Canada
[4] Univ Hlth Network, Dept Med, Toronto, ON, Canada
[5] Princess Margaret Canc Ctr, Dept Surg Oncol, Div Urol, Toronto, ON, Canada
[6] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
关键词
Prostate cancer; Low-risk disease; Active surveillance; Physical activity; Treatment; EXERCISE; LIFE;
D O I
10.1007/s10552-019-01211-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Epidemiologic data suggest that high levels of physical activity (PA) may reduce the risk of disease progression in men with prostate cancer (PCa), but it is unknown whether PA can delay the requirement for definitive treatment for those on active surveillance (AS). We investigated the influence of PA post-diagnosis on AS discontinuation in men with low-risk disease. Methods The effect of PA on the time to AS discontinuation was assessed in 421 patients, of whom 107 underwent additional PCa treatment over a median of 2.5 years. Results Using Cox regression models, we found that PA was not significantly associated with time to curative treatment initiation. Prostate-specific antigen (PSA) most proximal to AS initiation (HR, 1.11; 95% CI 1.03 to 1.21) and the number of positive cores (HR, 1.34; 95% CI 1.12 to 1.61) at diagnosis were associated with a significantly increased risk of discontinuing AS. Conclusion Our findings suggest that PA during AS for PCa does not significantly influence time to curative treatment.
引用
收藏
页码:1009 / 1012
页数:4
相关论文
共 50 条
  • [1] Influence of physical activity on active surveillance discontinuation in men with low-risk prostate cancer
    Efthymios Papadopoulos
    Shabbir M. H. Alibhai
    George A. Tomlinson
    Andrew G. Matthew
    Michael Nesbitt
    Antonio Finelli
    John Trachtenberg
    Daniel Santa Mina
    Cancer Causes & Control, 2019, 30 : 1009 - 1012
  • [2] Active surveillance for men with low-risk prostate cancer
    Sturch, Paul
    Kirby, Roger
    Challacombe, Ben
    TRENDS IN UROLOGY & MENS HEALTH, 2014, 5 (02) : 14 - 16
  • [3] Active Surveillance for Black Men With Low-Risk Prostate Cancer
    Shen, Xinglei
    Pettaway, Curtis A.
    Chen, Ronald C.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (17): : 1733 - 1734
  • [4] THE QUALITY OF ACTIVE SURVEILLANCE FOR MEN WITH LOW-RISK PROSTATE CANCER
    Levy, Mya E.
    Meyers, Stephanie
    Wood, David P.
    Montie, James E.
    Miller, David C.
    Wei, John T.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 179 - 179
  • [5] USE OF HOLEP IN MEN ON ACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER
    Schober, Jared
    Stensland, Kristian
    Mandeville, Jessica
    Moinzadeh, Alireza
    Canes, David
    JOURNAL OF UROLOGY, 2020, 203 : E1188 - E1188
  • [6] Active surveillance for low-risk prostate cancer
    Klotz, Laurence
    CURRENT OPINION IN UROLOGY, 2017, 27 (03) : 225 - 230
  • [7] Active surveillance for low-risk prostate cancer
    Herlemann, Annika
    Stief, Christian G.
    UROLOGE, 2016, 55 (02): : 269 - 278
  • [8] Active Surveillance for Low-Risk Prostate Cancer
    Laurence Klotz
    Current Urology Reports, 2015, 16
  • [9] Active Surveillance for Low-risk Prostate Cancer
    Mazzucchelli, Roberta
    Nesseris, Ioannis
    Cheng, Liang
    Lopez-Beltran, Antonio
    Montironi, Rodolfo
    Scarpelli, Marina
    ANTICANCER RESEARCH, 2010, 30 (09) : 3683 - 3692
  • [10] Active Surveillance for Low-Risk Prostate Cancer
    Klotz, Laurence
    CURRENT UROLOGY REPORTS, 2015, 16 (04) : 1 - 10